Company
Medacta Group SA
Headquarters: Castel San Pietro, Switzerland
Employees: 1,246
Market Cap
CHF2.12 Billion
CHF as of Jan. 1, 2025
US$2.34 Billion
Medacta Group SA Categories
Switzerland Healthcare Medical DevicesSwitzerland Healthcare Switzerland Medical Devices
Top Competitors by Market Capitalization
Industry: Medical Devices
| Company | Market Cap (USD) |
|---|---|
| Abbott | $213.72 B |
| Stryker | $150.01 B |
| Boston Scientific Corporation | $149.80 B |
| Medtronic | $114.44 B |
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $47.37 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
Medacta Group SA develops, manufactures, and distributes orthopedic and spinal surgery medical devices in Europe, North America, the Asia-Pacific, and internationally. It offers personalized kinematic models and 3D planning tools for use in hip, knee, shoulder, sports medicine, and spine procedures. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.
Financials
| Last Financial Reports Date | Dec. 31, 2023 |
| Revenue TTM | CHF506.8 M |
| EBITDA | CHF121.7 M |
| Gross Profit TTM | CHF347.8 M |
| Profit Margin | 10.33% |
| Operating Margin | 15.78% |
| Quarterly Revenue Growth | 13.10% |
Stocks & Indices
Medacta Group SA has the following listings and related stock indices.
Stock: SIX: MOVE wb_incandescent